Neopharmed Gentili donates 50,000 euros to the Italian Red Cross to help the people affected by the earthquake in Turkey and Syria
Milan, 9 March 2023– The pharmaceutical company Neopharmed Gentili participates with a donation of 50,000 euros in the fundraising launched by the Italian Red Cross (CRI) in favor of communities affected by the violent earthquake in Turkey and Syria. The funds will be used to support the activities of Volunteers and Red Cross operators engaged in the front line of operations to support populations who are experiencing a situation of serious difficulty.
“With this donation, Neopharmed Gentili wanted to testify in a concrete way its closeness and support to the Turkish and Syrian populations in such a dramatic moment for the many families forced to deal with the devastation of the earthquake, which adds to the human tragedy of the thousands of people who lost their lives”, comments Alessandro Del Bono, CEO of Neopharmed Gentili. “As has already happened in other situations of humanitarian emergency, we have made ourselves available to the Italian Red Cross in favor of those who are most in need. Solidarity is in the DNA of our company, which has always been close to the weakest and most vulnerable people”.
“What happened in Turkey and Syria destabilized the world. The earthquake devastated entire areas, causing thousands of deaths and injuries, – underlines Rosario Valastro, President of the Italian Red Cross – and destroyed hundreds of homes. After the earthquake, the Italian Red Cross launched a fundraiser to support the populations affected by this serious crisis. Many companies and people have joined this initiative. I thank Neopharmamed Gentili and all the partners who have shown great sensitivity and the desire to help the communities affected by the earthquake, reaching out to them and supporting them in this difficult moment”.
Neopharmed Gentili invites all those who can to join the fundraising activated by the Italian Red Cross to respond to the humanitarian and health needs to which the volunteers of the Turkish and Syrian Red Crescent are responding relentlessly.
Further information is available on the site: https://cri.it/terremototurchiasiria/
About Neopharmed Gentili
Neopharmed Gentili is a pharmaceutical company born in Italy and historically rooted in its territory, with strong expansion beyond national borders thanks to a consolidated and reliable experience in M&A and Licensing operations, especially with multinational partners. Research, responsibility and care are the pillars that guide Neopharmed Gentili’s mission to improve the health and quality of life of patients, caregivers and healthcare personnel. Neopharmed Gentili’s aspiration is to help people live a healthy and longest life possible, acting with ethical value and scientific precision, and offering solutions with high therapeutic value.
For more information:
Neopharmed Gentili press office
Value Relations
Angela Del Giudice
Mob. 392.6858392 | a.delgiudice@vrelations.it
Chiara Farroni
Mob. 331.4997375 | c.farroni@vrelations.it
Read the press review
